These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 3033639)
1. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene. Garg LC; DiAngelo S; Jacob ST Proc Natl Acad Sci U S A; 1987 May; 84(10):3185-8. PubMed ID: 3033639 [TBL] [Abstract][Full Text] [Related]
2. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Zhang H; Wang JC; Liu LF Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214 [TBL] [Abstract][Full Text] [Related]
3. Topoisomerases and yeast rRNA transcription: negative supercoiling stimulates initiation and topoisomerase activity is required for elongation. Schultz MC; Brill SJ; Ju Q; Sternglanz R; Reeder RH Genes Dev; 1992 Jul; 6(7):1332-41. PubMed ID: 1321070 [TBL] [Abstract][Full Text] [Related]
4. A purified fraction containing RNA polymerase I that can accurately transcribe rat ribosomal RNA gene. Kurl RN; Rothblum LI; Jacob ST Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6672-5. PubMed ID: 6593724 [TBL] [Abstract][Full Text] [Related]
5. Camptothecin-sensitive relaxation of supercoiled DNA by the topoisomerase I-like activity associated with poly(ADP-ribose) polymerase-1. Yung TM; Parent M; Ho EL; Satoh MS J Biol Chem; 2004 Mar; 279(12):11992-9. PubMed ID: 14715657 [TBL] [Abstract][Full Text] [Related]
6. Characterization of ribosomal RNA synthesis in a gene dosage mutant: the relationship of topoisomerase I and chromatin structure to transcriptional activity. Muscarella DE; Vogt VM; Bloom SE J Cell Biol; 1987 Oct; 105(4):1501-13. PubMed ID: 2822724 [TBL] [Abstract][Full Text] [Related]
7. Site-specific in vivo cleavages by DNA topoisomerase I in the regulatory regions of the 35 S rRNA in Saccharomyces cerevisiae are transcription independent. Vogelauer M; Camilloni G J Mol Biol; 1999 Oct; 293(1):19-28. PubMed ID: 10512712 [TBL] [Abstract][Full Text] [Related]
8. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene. Stewart AF; Schütz G Cell; 1987 Sep; 50(7):1109-17. PubMed ID: 2887294 [TBL] [Abstract][Full Text] [Related]
9. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Hertzberg RP; Caranfa MJ; Hecht SM Biochemistry; 1989 May; 28(11):4629-38. PubMed ID: 2548584 [TBL] [Abstract][Full Text] [Related]
10. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome. Wong ML; Hsu MT J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Andoh T; Ishii K; Suzuki Y; Ikegami Y; Kusunoki Y; Takemoto Y; Okada K Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5565-9. PubMed ID: 3039492 [TBL] [Abstract][Full Text] [Related]
12. Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription. Rose KM; Szopa J; Han FS; Cheng YC; Richter A; Scheer U Chromosoma; 1988; 96(6):411-6. PubMed ID: 2851418 [TBL] [Abstract][Full Text] [Related]
13. Optimum DNA relaxation reaction conditions for calf thymus DNA-topoisomerase I are determined by specific enzyme features. Coderoni S; Paparelli M; Gianfranceschi GL Mol Biol Rep; 1990 Nov; 14(4):255-9. PubMed ID: 1965603 [TBL] [Abstract][Full Text] [Related]
14. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Bendixen C; Thomsen B; Alsner J; Westergaard O Biochemistry; 1990 Jun; 29(23):5613-9. PubMed ID: 1696837 [TBL] [Abstract][Full Text] [Related]
15. Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an approximately 200 bp repeating structure. Culotta V; Sollner-Webb B Cell; 1988 Feb; 52(4):585-97. PubMed ID: 2830030 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Jaxel C; Kohn KW; Wani MC; Wall ME; Pommier Y Cancer Res; 1989 Mar; 49(6):1465-9. PubMed ID: 2538227 [TBL] [Abstract][Full Text] [Related]
17. Transcription of eukaryotic ribosomal RNA gene. Jacob ST Mol Cell Biochem; 1986 Apr; 70(1):11-20. PubMed ID: 3012322 [TBL] [Abstract][Full Text] [Related]
18. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA. Lin JH; Castora FJ Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a factor that can prevent random transcription of cloned rDNA and its probable relationship to poly(ADP-ribose) polymerase. Kurl RN; Jacob ST Nucleic Acids Res; 1985 Jan; 13(1):89-101. PubMed ID: 2987793 [TBL] [Abstract][Full Text] [Related]
20. The effects of camptothecin on RNA polymerase II transcription: roles of DNA topoisomerase I. Capranico G; Ferri F; Fogli MV; Russo A; Lotito L; Baranello L Biochimie; 2007 Apr; 89(4):482-9. PubMed ID: 17336444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]